Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Suppression of choroidal neovascularization and quantitative and qualitative inhibition of VEGF and CCL2 by heparin.

Suppression of choroidal neovascularization and quantitative and qualitative inhibition of VEGF and CCL2 by heparin. Invest Ophthalmol Vis Sci. 2011 May 16; 52(6):3193-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.